HATAY PHARMACEUTICAL JOINT STOCK COMPANY

Being formed in 1965, the subject has experience in the field of manufacturing and trading pharmaceutical products. Its material for production is imported from foreign countries such as China, Taiwan, Germany, South Korea, France, India, the United Kingdom, Australia, Japan, etc. And then its products are supplied domestically and internationally. As audited consolidated financial statement as of 31 Dec 2023, it has fourteen branches, one subsidiary company, and three related companies. 
As reported data, business operations were considered as good with satisfactory revenue and profit, as well as acceptable liquidity in FY 2023. In the first quarter of 2024, profit was not as good as the previous same period. The investment activities continued to increase this year, especially the subject recorded VND 729.1 billion in "Costs of construction in progress" for the new factory - Hataphar Hi-Tech Pharmaceutical Factory in Lang Hoa Lac Hi-Tech Park as of 31 Mar 2024. In general, business activities remained stable.